SCHEMBL28413523

SCHEMBL28413523

COC(=O)c1cccc(C(C)NC(=O)c2cc(NC(=O)C(C)C)ccc2N(C)C)c1

nearest known ligand 0.73

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
KCNB1 Q14721 16/20 0.73
KCNB2 Q92953 1/20 0.73
KCNA5 P22460 6/20 0.53
KCNH2 Q12809 5/20 0.53
KCNK2 O95069 2/20 0.52
MEN1 O00255 1/20 0.42
NPC1 O15118 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
MAPT P10636 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
RAB9A P51151 1/20 0.42
KMT2A Q03164 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29793705 0.85 KCNB1 (1.00) KCNB1KCNB2KCNA5KCNH2KCNK2
SCHEMBL28402250 0.83 KCNB1 (0.83) KCNB1KCNB2KCNA5KCNH2KCNK2
SCHEMBL28410651 0.83 KCNB1 (0.78) KCNB1KCNA5KCNH2KCNK2
SCHEMBL28257417 0.83 KCNB1 (0.48) KCNB1KCNB2CYP3A4CYP2D6CYP2C9
SCHEMBL28406389 0.82 KCNB1 (0.72) KCNB1KCNB2KCNA5KCNH2CYP3A4
SCHEMBL28406386 0.80 ALDH1A1 (0.49) KCNB1KCNB2MEN1CYP1A2CYP3A4
SCHEMBL28410953 0.79 KCNB1 (0.68) KCNB1KCNB2KCNA5KCNH2KCNK2
SCHEMBL28257357 0.77 KCNB1 (0.76) KCNB1KCNB2KCNA5KCNH2KCNK2
SCHEMBL29793564 0.76 KCNB1 (0.75) KCNB1KCNB2KCNA5KCNH2KCNK2
SCHEMBL28408023 0.76 KCNB1 (0.75) KCNB1KCNB2KCNA5KCNH2KCNK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108929263-B Arylamide Kv2.1 inhibitor and preparation method, pharmaceutical composition and application thereof 中国医学科学院药物研究所 2022-07-22 CN disclosed
CN-111108092-A Arylamide Kv2.1 inhibitor and preparation method, pharmaceutical composition and application thereof 中国医学科学院药物研究所 2020-05-05 CN disclosed